Cargando…

Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance

PURPOSE: The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which dire...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Fanqi, Zou, Le, Zhang, Tengyu, Jiang, Lei, Ding, Yao, Yu, Peng, Peng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112789/
https://www.ncbi.nlm.nih.gov/pubmed/30197538
http://dx.doi.org/10.2147/CMAR.S164766
_version_ 1783350904466964480
author Meng, Fanqi
Zou, Le
Zhang, Tengyu
Jiang, Lei
Ding, Yao
Yu, Peng
Peng, Jie
author_facet Meng, Fanqi
Zou, Le
Zhang, Tengyu
Jiang, Lei
Ding, Yao
Yu, Peng
Peng, Jie
author_sort Meng, Fanqi
collection PubMed
description PURPOSE: The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which directly leads to chemotherapy failure. However, most of the currently used detection methods in MDR-related studies are qualitative or semiquantitative, but not quantitative. As a result, the measurement criteria of different experiments are not unified. Moreover, there are many contradictory results of the studies of the induction effect of drugs on ABC transporters. So, it is necessary to establish a quantitative assay for the quantification of P-gp, MRP1, and BCRP to study the mechanism of drug resistance. METHODS: In this paper, a novel and advanced liquid chromatography/mass spectrometry (MS)/MS-based targeted proteomics method for the quantification of P-gp, MRP1, and BCRP was developed and validated. Then, the cell lines MCF-7, HepG-2, and SMMC-7721 were, respectively, induced by different concentrations of doxorubicin (adriamycin [ADM]), mitoxantrone (MX), and methotrexate (MTX), to establish resistance cell lines. The method established was used to quantify the expression of P-gp, MRP1, and BCRP. RESULTS: The result showed that the induction effects of drugs on protein were relatively stable and selective. ADM, MX, and MTX could induce overexpression of P-gp, MRP1, and BCRP. And, the induction effect of different drugs on proteins was selective. The pattern of overexpression of ABC transporters in the three types of resistance cell lines was different. CONCLUSION: During the development of drug resistance, the cell type and patch, but not drug type, were the most important determinant factors of the overexpression level of ABC transporters in resistance cell lines. This study provides a good foundation for understanding the development of drug resistance in cell lines and can be used to explain the contradictory results in other published studies as described above.
format Online
Article
Text
id pubmed-6112789
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61127892018-09-07 Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance Meng, Fanqi Zou, Le Zhang, Tengyu Jiang, Lei Ding, Yao Yu, Peng Peng, Jie Cancer Manag Res Original Research PURPOSE: The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which directly leads to chemotherapy failure. However, most of the currently used detection methods in MDR-related studies are qualitative or semiquantitative, but not quantitative. As a result, the measurement criteria of different experiments are not unified. Moreover, there are many contradictory results of the studies of the induction effect of drugs on ABC transporters. So, it is necessary to establish a quantitative assay for the quantification of P-gp, MRP1, and BCRP to study the mechanism of drug resistance. METHODS: In this paper, a novel and advanced liquid chromatography/mass spectrometry (MS)/MS-based targeted proteomics method for the quantification of P-gp, MRP1, and BCRP was developed and validated. Then, the cell lines MCF-7, HepG-2, and SMMC-7721 were, respectively, induced by different concentrations of doxorubicin (adriamycin [ADM]), mitoxantrone (MX), and methotrexate (MTX), to establish resistance cell lines. The method established was used to quantify the expression of P-gp, MRP1, and BCRP. RESULTS: The result showed that the induction effects of drugs on protein were relatively stable and selective. ADM, MX, and MTX could induce overexpression of P-gp, MRP1, and BCRP. And, the induction effect of different drugs on proteins was selective. The pattern of overexpression of ABC transporters in the three types of resistance cell lines was different. CONCLUSION: During the development of drug resistance, the cell type and patch, but not drug type, were the most important determinant factors of the overexpression level of ABC transporters in resistance cell lines. This study provides a good foundation for understanding the development of drug resistance in cell lines and can be used to explain the contradictory results in other published studies as described above. Dove Medical Press 2018-08-23 /pmc/articles/PMC6112789/ /pubmed/30197538 http://dx.doi.org/10.2147/CMAR.S164766 Text en © 2018 Meng et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Meng, Fanqi
Zou, Le
Zhang, Tengyu
Jiang, Lei
Ding, Yao
Yu, Peng
Peng, Jie
Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
title Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
title_full Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
title_fullStr Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
title_full_unstemmed Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
title_short Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
title_sort using lc–ms/ms-based targeted proteomics to monitor the pattern of abc transporters expression in the development of drug resistance
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112789/
https://www.ncbi.nlm.nih.gov/pubmed/30197538
http://dx.doi.org/10.2147/CMAR.S164766
work_keys_str_mv AT mengfanqi usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance
AT zoule usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance
AT zhangtengyu usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance
AT jianglei usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance
AT dingyao usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance
AT yupeng usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance
AT pengjie usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance